Edition:
United States

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

38.62USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$38.62
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
208,963
52-wk High
$96.51
52-wk Low
$35.80

Chart for

About

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a... (more)

Overall

Beta: --
Market Cap(Mil.): $3,132.52
Shares Outstanding(Mil.): 35.82
Dividend: --
Yield (%): --

Financials

  ONCE.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -6.38 -- --
ROI: -61.15 0.28 15.02
ROE: -63.88 0.94 16.60

BRIEF-European Commission Approves Spark Therapeutics' Luxturna

* EUROPEAN COMMISSION APPROVES SPARK THERAPEUTICS' LUXTURNA® (VORETIGENE NEPARVOVEC), A ONE-TIME GENE THERAPY FOR INHERITED RETINAL DISEASE CAUSED BY CONFIRMED BIALLELIC RPE65 MUTATIONS Source text for Eikon: Further company coverage:

Nov 23 2018

Earnings vs. Estimates